Showing results (3831-3840 of 6,795) with videos related to
Sort By:
Pageof 680
Clinical Therapeutics|July 9, 1999
Switching from therapy with typical antipsychotic agents to risperidone: long-term impact on patient outcomeA K Malla, R M Norman, V Kotteda, et al.Clinical Therapeutics|July 9, 1999
Modeling economic evaluations of pharmaceuticals: manipulation or valuable tool?Z M Khan, D W MillerClinical Therapeutics|August 27, 1999
Factors contributing to trends in prescription drug expendituresD C Suh, C R Lacy, J A Barone, et al.Clinical Therapeutics|November 24, 1999
Metformin as secondary therapy in a defined population with type 2 diabetesJ B Brown, K L PedulaClinical Therapeutics|November 24, 1999
The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis. Phase II Rofecoxib Rheumatoid Arthritis Study GroupT J Schnitzer, K Truitt, R Fleischmann, et al.Clinical Therapeutics|November 24, 1999
Pharmacokinetics of etodolac in patients with stable juvenile rheumatoid arthritisJ P Boni, J M Korth-Bradley, P Martin, et al.Clinical Therapeutics|November 24, 1999
Adverse effects of benzalkonium chloride on the nasal mucosa: allergic rhinitis and rhinitis medicamentosaP GrafClinical Therapeutics|November 24, 1999
Double-masked comparison of the quality of life of hypercholesterolemic men treated with simvastatin or pravastatin. International Quality of Life Multicenter GroupM Seed, M R WeirClinical Therapeutics|September 1, 1993
Reduction of hospital days in chronic schizophrenic patients treated with risperidone: a retrospective studyD E Addington, B Jones, D Bloom, et al.Clinical Therapeutics|January 1, 1980
Diflucortolone valerate (Nerisona): a comparative vasoconstriction test in artificially induced hyperemia of the skinR Reckers, H WendtPageof 680